article thumbnail

Top biopharmaceutical Covid-19 vaccine companies boosted with over 80% revenue growth

Pharmaceutical Technology

Last year was a positive year for biopharmaceutical companies, particularly those with Covid-19 vaccines. As a result of huge global sales of mRNA Covid-19 vaccines, the split in profits between Pfizer and BioNTech’s Comirnaty contributed towards revenues of $81.3bn and $22.4bn last year, respectively. YoY revenue growth.

article thumbnail

India: Why is the country ramping up drug discovery research?

Drug Discovery World

DDW’s Megan Thomas takes a deeper look into why India is ramping up drug discovery research, and explores the country’s innovation hubs of interest. Similarly, The Times of India says that branded generic medicines have “long fuelled India’s pharmaceutical exports” 4.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA Approves First Generic of Symbicort to Treat Asthma and COPD

The Pharma Data

Agency Supports Development of Complex Generic Drug-Device Combination Product to Improve Competition and Access to More Affordable Medicines. This complex generic drug-device combination product, which is a metered-dose inhaler, should not be used to treat acute asthma attacks. Today, the U.S.

article thumbnail

Recon: Moderna lifts guidance on COVID vaccine sales; US backing of patent waiver causes stir

The Pharma Data

. US backs giving poorer countries access to COVID-19 vaccine patents, reversing stance ( Reuters ) ( STAT ) ( NYTimes ) ( Endpoints ) ( Harvard Bill of Health ) ( KEI ) ( Patent Docs ). Drugmakers say Biden misguided over vaccine patent waiver ( Reuters ) ( FT ). billion ( Reuters ) ( WSJ ). Reps.

Sales 52
article thumbnail

Drug discovery hotspots: India’s Genome Valley

Drug Discovery World

India is traditionally known as ‘the pharmacy of the world’ due to its huge pharmaceuticals manufacturing capacity and high quantity of exports, particularly generic medicines and vaccines. Historically, this has been predominantly driven by generic drugs, with branded generics making up 70-80% of the retail market.

Genome 52
article thumbnail

‘Right shoring’ API production in Europe

Pharmaceutical Technology

During the pandemic, the shortage of basic drugs such as paracetamol in key EU countries led to growing calls to push local drug manufacturing to ensure a smooth supply and to minimise shortages. Only 25% of API production for generic drugs took place in Europe in 2020, according to a November 2022 Medicines for Europe report.

article thumbnail

COVID-19 Pandemic Coverage

XTalks

Vaccine Nationalism” Could Prove the Undoing of COVID-19 Containment. Tension is mounting as nations big and small jockey around industry to ensure they are first in line to access a vaccine, should one prove to be successful against COVID-19. Moderna’s COVID-19 Vaccine. The price of that prize is incalculable.